Pirtobrutinib in the Bruton tyrosine kinase landscape in chronic lymphocytic leukemia: incremental advance or new standard?
Acta Haematologica Polonica · 29.10.2026 · 57 (5) · 403-412
DOI: 10.5603/ahp.113755 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Haematologica Polonica, online erschienen am 29.10.2026. Verfasst von Agnieszka Wysocka und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wysocka, A., Kościelny, K., Ryżewska, W., Gołos, A., Hut-Bogołębska, M., Kępski, J., Robak, T., & Puła, B. (2026). Pirtobrutinib in the Bruton tyrosine kinase landscape in chronic lymphocytic leukemia: incremental advance or new standard?. Acta Haematologica Polonica, 57(5), 403-412. https://doi.org/10.5603/ahp.113755
Vancouver
Wysocka A, Kościelny K, Ryżewska W, Gołos A, Hut-Bogołębska M, Kępski J, et al. Pirtobrutinib in the Bruton tyrosine kinase landscape in chronic lymphocytic leukemia: incremental advance or new standard?. Acta Haematologica Polonica. 2026;57(5):403-412. doi:10.5603/ahp.113755
BibTeX
@article{Wysocka2026,
author = {Wysocka, Agnieszka and Kościelny, Kacper and Ryżewska, Wiktoria and Gołos, Aleksandra and Hut-Bogołębska, Malwina and Kępski, Jarosław and Robak, Tadeusz and Puła, Bartosz},
title = {Pirtobrutinib in the Bruton tyrosine kinase landscape in chronic lymphocytic leukemia: incremental advance or new standard?},
journal = {Acta Haematologica Polonica},
year = {2026},
volume = {57},
number = {5},
pages = {403--412},
doi = {10.5603/ahp.113755}
}
EUVIMED